Ventas, Inc. (VTR) is a REIT - Healthcare Facilities company in the Real Estate sector, currently trading at $85.34. It has a SharesGrow Score of 42/100, indicating a mixed investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of VTR = $48.01 (-43.7% from the current price, the stock appears overvalued). Analyst consensus target is VTR = $90 (+5.8% upside).
Valuation: VTR trades at a trailing Price-to-Earnings (P/E) of 158.3 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.29.
Financials: revenue is $5.8B, +12.3%/yr average growth. Net income is $251M, growing at +169.2%/yr. Net profit margin is 4.3% (thin). Gross margin is -5.9% (-50.6 pp trend).
Balance sheet: total debt is $13.2B against $12.5B equity (Debt-to-Equity (D/E) ratio 1.06, moderate). Current ratio is 0.96 (tight liquidity). Debt-to-assets is 47.9%. Total assets: $27.6B.
Analyst outlook: 19 / 32 analysts rate VTR as buy (59%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 24/100 (Fail), Growth 90/100 (Pass), Past 50/100 (Partial), Health 17/100 (Fail), Moat 30/100 (Fail), Future 52/100 (Partial), Income 30/100 (Fail).
